Activator protein-2 inhibits survivin gene expression in Hela cells
LI Feng-zh
Abstract
LI Feng-zh
Abstract
Objective To elucidate the impacts of activator protein-2 (AP-2) on survivin gene expression in Hela cells and to provide a theoretical and clinical basis for targeted suppression of survivin gene. Methods The survivin promoter and AP-2 were cotransfected into Hela cells to detect the impacts of AP-2 on activities of survivin promoter. The regulation of the survivin expression by AP-2 was detected with RT-PCR and Western blotting after transfection. Results AP-2 was shown to inhibit the activity of survivin core promoter in Hela cells. In addition, AP-2 also inhibited survivin expression at the transcription and translation levels in Hela cells. Conclusion Inhibition of survivin expression in Hela cells by AP-2 may open up a new approach for effective regulation of survivin gene and provide a potential base for survivin-targeted cancer therapy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To elucidate the impacts of activator protein-2 (AP-2) on survivin gene expression in Hela cells and to provide a theoretical and clinical basis for targeted suppression of survivin gene. Methods The survivin promoter and AP-2 were cotransfected into Hela cells to detect the impacts of AP-2 on activities of survivin promoter. The regulation of the survivin expression by AP-2 was detected with RT-PCR and Western blotting after transfection. Results AP-2 was shown to inhibit the activity of survivin core promoter in Hela cells. In addition, AP-2 also inhibited survivin expression at the transcription and translation levels in Hela cells. Conclusion Inhibition of survivin expression in Hela cells by AP-2 may open up a new approach for effective regulation of survivin gene and provide a potential base for survivin-targeted cancer therapy.
Key concepts: Survivin, HeLa, Activator (genetics), Transfection, Molecular biology, Promoter, Transcription (linguistics), Cancer research